Gene-editing trials are optimistic and Tesla stocks are going ballistic, but first: a cartoon about meme cinema. Here's the news you need to know, in two minutes or less. Want to receive this two-minute roundup as an email every weekday? Sign up here! Today’s News Crispr-edited cells show promise in first US human safety trial Initial reports on the safety of the nation’s first in-human test of the disease-fighting potential of Crispr gene editing are here: So far, so good.
Learn about your ad choices:
dovetail.prx.org/ad-choices
